Paper · 33249552
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.
Turkoz I and 8 others. Acta Psychiatr Scand, 2021. Cited by 86 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression. Papers, record 33249552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33249552
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Major Depressive Disorder | Major topic |
| Depressive Disorder, Treatment-Resistant | Major topic |
| Adult | |
| Depression | |
| Double-Blind Method | |
| Humans | |
| Patient Reported Outcome Measures | |
| Treatment Outcome |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,881,538 | The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. | J Clin Psychiatry | 1998 | https://conductscience.org/library/papers/9881538 | PubMed |
| 2 | 32,448,035 | One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials. | J Psychopharmacol | 2020 | https://conductscience.org/library/papers/32448035 | PubMed |
| 3 | 32,016,303 | Measuring Clinical Importance in a Trial of Interventions for Mixed Urinary Incontinence. | JAMA | 2020 | https://conductscience.org/library/papers/32016303 | PubMed |
| 4 | 22,759,625 | Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care. | BMC Psychiatry | 2012 | https://conductscience.org/library/papers/22759625 | PubMed |
| 5 | 30,537,955 | Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review. | Health Qual Life Outcomes | 2018 | https://conductscience.org/library/papers/30537955 | PubMed |
| 6 | 32,105,798 | Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. | J Clin Epidemiol | 2020 | https://conductscience.org/library/papers/32105798 | PubMed |
| 7 | 22,231,681 | Enhancing the clinical utility of depression screening. | CMAJ | 2012 | https://conductscience.org/library/papers/22231681 | PubMed |
| 8 | 12,755,850 | The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. | Acta Psychiatr Scand Suppl | 2003 | https://conductscience.org/library/papers/12755850 | PubMed |
| 9 | 16,390,886 | Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. | Am J Psychiatry | 2006 | https://conductscience.org/library/papers/16390886 | PubMed |
| 10 | 16,794,566 | Report by the ACNP Task Force on response and remission in major depressive disorder. | Neuropsychopharmacology | 2006 | https://conductscience.org/library/papers/16794566 | PubMed |
1 to 10 of 31
See all 31 referencesCited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,766,497 | Supporting the Primary Outcomes of the Mirai Trial for the Adjunctive Digital Therapeutic Rejoyn (CT-152) in the Treatment of Major Depressive Disorder: Meaningful Change Analysis in the Montgomery-Åsberg Depression Rating Scale. | JMIR Form Res | 2026 | https://conductscience.org/library/papers/42766497 | PubMed |
| 42,736,875 | Real-World Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Retrospective Observational Study. | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42736875 | PubMed |
| 42,662,408 | Patient characteristics, treatment patterns and clinical response in patients with treatment resistant depression starting a new treatment in the clinical setting: a multicenter, observational study in Portugal. | Front Psychiatry | 2026 | https://conductscience.org/library/papers/42662408 | PubMed |
| 42,658,837 | Efficacy and safety of 15 mA transcranial alternating current stimulation (tACS) in the therapy of treatment-resistant depression with increased inflammatory activity: Study protocol for a randomized, double-blind, sham-controlled trial. | PLoS One | 2026 | https://conductscience.org/library/papers/42658837 | PubMed |
| 42,548,550 | Residual depression symptoms following nature-based exercise therapies among U.S. service members. | Front Physiol | 2026 | https://conductscience.org/library/papers/42548550 | PubMed |
| 42,409,775 | Ecological assessment of transdiagnostic clinical symptoms in serious mental illness with daily smartphone surveys. | Transl Psychiatry | 2026 | https://conductscience.org/library/papers/42409775 | PubMed |
| 42,406,402 | Prefrontal Transcranial Pulse Stimulation for Major Depressive Disorder: A Randomized Clinical Trial. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42406402 | PubMed |
| 42,298,144 | Digital phenotyping with large language models to detect depressive state changes in patients. | NPJ Digit Med | 2026 | https://conductscience.org/library/papers/42298144 | PubMed |
| 42,291,481 | A home base for young adults: evidence that a primary care-embedded multidisciplinary rheumatology transition clinic improved care utilization and engagement. | Health Care Transit | 2026 | https://conductscience.org/library/papers/42291481 | PubMed |
| 42,284,258 | Efficacy and Moderators of Mindfulness-Based Cognitive Therapy in Difficult-to-Treat Depression: A Systematic Review and Individual Participant Data Meta-Analysis. | Psychother Psychosom | 2026 | https://conductscience.org/library/papers/42284258 | PubMed |
1 to 10 of 59
See all 59 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TTK | 7,272 | PubTator's text mining | https://conductscience.org/library/genes/7272 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33249552
GET https://conductscience.org/api/papers/v1/33249552/references?page=2